Incyte Corporation (NASDAQ:INCY) revealed results from its pivotal Phase 3 TRuE-PN clinical trial program –TRuE-PN1 and ...

Incyte's Phase 3 TRuE-PN trials show ruxolitinib cream improves itch relief in prurigo nodularis, though TRuE-PN2's primary ...

An autoimmune disease characterized by skin depigmentation, vitiligo has attained many stereotypes. This dermatological ...

New research shows gut-friendly bacteria may slow vitiligo progression, offering hope for millions with autoimmune disease.

Higher rates of venous thromboembolism, lymphoma, and infections were observed in those with atopic dermatitis and psoriasis vs control patients.

The global dermatology lasers market is set for substantial growth, increasing from USD 1,767.8 billion in 2023 to USD ...

World-leading photomedicine company CLINUVEL will make its début at the American Academy of Dermatology (AAD) Annual Meeting ...

The belief that consuming fish with dairy causes vitiligo is an ancient myth. Science confirms no link, though some may ...

Fintel reports that on February 27, 2025, Maxim Group initiated coverage of STRATA Skin Sciences (NasdaqCM:SSKN) with a Buy ...

Vitiligo is a condition characterized by a loss of pigment (melanin), which results in the most common symptom: white or ...

A Memorial University medical student is gaining recognition for his work researching and advocating for people diagnosed with vitiligo. The auto-immune disease causes the body to attack melanin in ...